SCHEMBL6498265

SCHEMBL6498265

COc1ccc(Br)c(C=CC(=O)N2CCC(C(=O)NC(C)C(=O)O)CC2)c1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.48
RAB9A P51151 4/20 0.48
ALDH1A1 P00352 2/20 0.48
PTGS2 P35354 3/20 0.44
PTGS1 P23219 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.43
GAA P10253 1/20 0.43
CAPN1 P07384 3/20 0.42
GPR183 P32249 2/20 0.41
APOBEC3A P31941 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6498264 1.00 NPC1 (0.48) NPC1RAB9AALDH1A1PTGS2PTGS1
SCHEMBL6505741 0.87 NPC1 (0.44) NPC1RAB9AALDH1A1PTGS2PTGS1
SCHEMBL6505746 0.87 NPC1 (0.44) NPC1RAB9AALDH1A1PTGS2PTGS1
SCHEMBL6504799 0.83 SMN1; SMN2 (0.51) NPC1RAB9AALDH1A1SMN1; SMN2CAPN1
SCHEMBL6504800 0.83 SMN1; SMN2 (0.51) NPC1RAB9AALDH1A1SMN1; SMN2CAPN1
SCHEMBL6497505 0.80 NPC1 (0.47) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL6500473 0.79 SMN1; SMN2 (0.66) NPC1RAB9ASMN1; SMN2CAPN1GPR183
SCHEMBL6496329 0.79 SMN1; SMN2 (0.55) NPC1RAB9ASMN1; SMN2CAPN1GPR183
SCHEMBL6502814 0.79 NPC1 (0.46) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL6496819 0.79 KDM4E (0.48) NPC1RAB9AALDH1A1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed